NCT03999658 2023-05-01A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory MalignanciesSorrento Therapeutics, Inc.Phase 2 Withdrawn
NCT03644056 2020-05-28Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid TumorsImmuneOncia Therapeutics Inc.Phase 1 Completed15 enrolled